Di Marco A

439 total citations
28 papers, 355 citations indexed

About

Di Marco A is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Di Marco A has authored 28 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Di Marco A's work include Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (6 papers) and Virus-based gene therapy research (4 papers). Di Marco A is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (6 papers) and Virus-based gene therapy research (4 papers). Di Marco A collaborates with scholars based in Italy. Di Marco A's co-authors include Graziella Pratesi, Federico Arcamone, Giuseppe Cassinelli, Fernando C. Giuliani, Luigi Lenaz, Franco Zunino, Romolo A. Gambetta, A. Zaccara, Marco Casazza and A. Necco and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Di Marco A

26 papers receiving 320 citations

Peers

Di Marco A
Comparison fields: 5 of 60
  • Oncology 214
  • Cardiology and Cardiovascular Medicine 153
  • Molecular Biology 146
  • Pulmonary and Respiratory Medicine 36
  • Hematology 33
Replace Stefan A. Cohen with:
Stefan A. Cohen United States
C. Norman Coleman United States
H Majima Japan
Mellett Lb
Marsha Jones United States
Masanori Umeda Japan
Susanne Vejda Austria
Michelle S. Miller United States
C. P. Eng Canada
P. Vermylen Belgium
Stefan A. Cohen United States View profile →
Citations per field, relative to Di Marco A
Di Marco A · 1×
Citations per year, relative to Di Marco A
Di Marco A · 1×

Countries citing papers authored by Di Marco A

Since Specialization
Citations

This map shows the geographic impact of Di Marco A's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Marco A with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Marco A more than expected).

Fields of papers citing papers by Di Marco A

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Marco A. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Marco A. The network helps show where Di Marco A may publish in the future.

Co-authorship network of co-authors of Di Marco A

This figure shows the co-authorship network connecting the top 25 collaborators of Di Marco A. A scholar is included among the top collaborators of Di Marco A based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Marco A. Di Marco A is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
[Studies on a new antibiotic with antitumor action: Distamycin-Fraction A].
1
2
[Immunoelectrophoretic studies of the nucleoproteins of normal and neoplastic hepatic tissue].
0
3
[Wolfram syndrome. Peculiar urologic aspects].
1
4
Primary non Hodgkin lymphomas of the brain: radiological findings.
1
5
Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
23
6
The discovery of daunorubicin.
51
7
Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
12
8
Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
6
9
A comparison of the effects of daunomycin and adriamycin on various DNA polymerases.
38
10
Biologic activity of some adriamycin (NSC-123127) derivatives.
5
11
Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
6
12
On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
12
13
Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
21
14
Interference of daunomycin and adriamycin on the growth and aggression of murine sarcoma virus (Moloney) tumors in mice.
16
15
Distribution of tritiated daunomycin (NSC-82151) in normal rats.
11
16
[Metabolic transformation of daunomycin by tissue extracts].
1
17
[On 7 cases of congenital toxoplasmosis with special reference to cases with atypical symptomatology].
1
18
[Pharmacology of new basic oligosaccharide antibiotics].
1
19
[On paralysis of the sciatic nerve caused by intragluteal injections of drugs].
1
20
[Antibacterial activity of a tensioactive diguanidine derivative].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026